- Brand names:
- Pharmaceutical Company:
- Condition/Indication:
- Meeting Date: July 2013
- Public Summary Document (PSD) July 2013 PBAC Meeting - PDF
Pazopanib – July 2013
Pazopanib, film-coated tablets, 200 mg and 400 mg (as hydrochloride), Votrient®
Last updated
8 November 2023